Haematology
| Full details for "Rivaroxaban". | |
|---|---|
Name |
Rivaroxaban |
Alternative name/Profile |
Xa inhibitor, Direct Oral Anticoagulant, DOAC |
Department |
Haematology |
Investigation |
This assay is used to measure plasma concentrations of rivaroxaban. Routine measurement of rivaroxaban levels is not recommended. |
Specimen type |
Peripheral Blood |
Sample type |
|
Sample container & volume |
2 x 3ml Light Blue Tri-Sodium Citrate samples |
Frequency of analysis |
Weekly |
Turnaround time |
5 working days |
Availability |
Routine hours Monday - Friday 9am-5pm. |
Notes |
Routine monitoring of DOACs is not recommended. This test should only be ordered following consultation with the Clinical Coagulation Team. A level taken at 2-4 hours after a dose will represent a peak level. A level taken 24 hours after the last dose of Rivaroxaban is considered a trough level. Samples must be received in National Coagulation Laboratory, Centre for Laboratory Medicine and Molecular Pathology, by 4pm Monday - Friday. Enquiries during routine hours Monday - Friday 9am-5pm to 01 416 2049. The Coagulation Consultant on-call can be contacted through the hospital switchboard on 01 410 3000. Reporting units = ng/ml. |
Related links |
|
Reference range |
Clinical implications of the drug concentration of Direct Oral Anticoagulants is dependent on individual patient circumstances. Advice regarding interpretation of this result is available from the Clinical Coagulation team at SJH at 01 410 3000. |
Last updated |
Mon, 09 Nov 2026 08:09:04 GMT |